PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SGEN vs. MRNA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SGEN and MRNA is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

SGEN vs. MRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Seagen Inc. (SGEN) and Moderna, Inc. (MRNA). The values are adjusted to include any dividend payments, if applicable.

-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember20250
-71.97%
SGEN
MRNA

Key characteristics

Fundamentals

Market Cap

SGEN:

$43.15B

MRNA:

$13.38B

EPS

SGEN:

-$4.00

MRNA:

-$5.81

PEG Ratio

SGEN:

18.53

MRNA:

0.00

Returns By Period


SGEN

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

MRNA

YTD

-16.38%

1M

-16.90%

6M

-71.97%

1Y

-65.97%

5Y*

11.06%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SGEN vs. MRNA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SGEN

MRNA
The Risk-Adjusted Performance Rank of MRNA is 55
Overall Rank
The Sharpe Ratio Rank of MRNA is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of MRNA is 33
Sortino Ratio Rank
The Omega Ratio Rank of MRNA is 33
Omega Ratio Rank
The Calmar Ratio Rank of MRNA is 88
Calmar Ratio Rank
The Martin Ratio Rank of MRNA is 77
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SGEN vs. MRNA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Seagen Inc. (SGEN) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
No data
The chart of Calmar ratio for SGEN, currently valued at 0.00, compared to the broader market0.002.004.006.000.00-0.72
SGEN
MRNA


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-1.00
-1.07
SGEN
MRNA

Dividends

SGEN vs. MRNA - Dividend Comparison

Neither SGEN nor MRNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SGEN vs. MRNA - Drawdown Comparison


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-0.07%
-92.82%
SGEN
MRNA

Volatility

SGEN vs. MRNA - Volatility Comparison

The current volatility for Seagen Inc. (SGEN) is 0.00%, while Moderna, Inc. (MRNA) has a volatility of 25.90%. This indicates that SGEN experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember20250
25.90%
SGEN
MRNA

Financials

SGEN vs. MRNA - Financials Comparison

This section allows you to compare key financial metrics between Seagen Inc. and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab